Cancer-Specific Differences
With MYPG, you can obtain the unique genetic information about your cancer in order to make informed decisions. These results enable your healthcare team to create a personalized treatment plan based on the most up to date therapies and clinical trials.
Cancer is a genetic disease driven by mutations in genes that convert normal cells into cancer cells. Normally, the genes within a cell serve as the instruction manual for how the cell behaves and performs. In cancer, mutations within key genes cause uncontrollable growth and invasion. MYPG sequences the most important cancer genes for mutations that may provide the insight needed to best manage your cancer.Cancer-Specific Differences
Information about particular genes in your tumor cells and how they are different from normal cells can help physicians create a more personalized treatment plan for you.
The results from the test may provide more insight into cancer therapy, disease classification, or prognosis. Ongoing clinical trials that target your cancer may be identified.Personal Genome Diagnostics offers tests to identify specific information about your tumor and its genetic makeup.
Who is eligible
What we need
A list of possible treatment options specific for the genetic alterations found in your tumor.
These treatment options may include: • Clinical trials enrolling patients with your genetic alteration and tumor type• Therapies that are approved in your cancer type• Therapies that are approved in other cancer types
The PASS (PGDx Access Support Services) financial assistance program offers discounts to patients in compliance with US Department of Health and Human Services guidelines.
Eligibility is based on family size and income level.
Tiered discounts are available up to 100%.
To check your eligibility, submit an application form.
QUESTIONS?
Call us at 888-571-2163
or see below.
FAQ
©2019 Personal Genome Diagnostics, Inc. All Rights Reserved.
